OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO) (www.intlstemcell.com), the first company to perfect a method of creating human stem cells from unfertilized eggs, applauds President Obama’s signing of an executive order to allow funding of stem cell research. ISCO’s unique human stem cells, called “parthenogenetic” stem cells, have ethical advantages since they do not harm a viable human embryo and have medical advantages since they can be immune matched to hundreds of millions of people across the world.
